Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

NCT04526665 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Biliary Cirrhosis

Interventions

DRUG: Elafibranor 80mg
DRUG: Placebo

Sponsor

Ipsen